Back
Supernus Pharmaceuticals Stock Price Chart
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right here
Sell
38
SUPN
Supernus Pharmaceuticals
Last Price:
30.25
Seasonality Move:
12.2%
7 Day Trial
ALL ACCESS PASS
$
7
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SUPN is experiencing slight buying pressure.
Supernus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.08 | Buy |
| 20-day SMA: | 30.39 | Sell |
| 50-day SMA: | 31.56 | Sell |
| 200-day SMA: | 29.08 | Buy |
| 8-day EMA: | 30.11 | Buy |
| 20-day EMA: | 30.53 | Sell |
| 50-day EMA: | 30.75 | Sell |
| 200-day EMA: | 30.22 | Buy |
Supernus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.5 | Sell |
| Relative Strength Index (14 RSI): | 46.64 | Sell |
| Chaikin Money Flow: | 27599 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.39 - 32.67) | Sell |
| Bollinger Bands (100): | (27.5 - 32.08) | Buy |
Supernus Pharmaceuticals Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals Stock
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 30.27 while SUPN 8-day simple moving average is 30.08, which is a Buy signal.
- The stock price of SUPN is 30.27 while Supernus Pharmaceuticals 20-day SMA is 30.39, which makes it a Sell.
- Supernus Pharmaceuticals 50-day simple moving average is 31.56 while SUPN share price is 30.27, making it a Sell technically.
- SUPN stock price is 30.27 and Supernus Pharmaceuticals 200-day simple moving average is 29.08, creating a Buy signal.
SUPN Technical Analysis vs Fundamental Analysis
Sell
38
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a Sell
The current Supernus Pharmaceuticals [SUPN] share price is $30.27. The Score for SUPN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Supernus Pharmaceuticals Stock Info
Market Cap:
1.66B
Price in USD:
30.27
Share Volume:
266.79K
Supernus Pharmaceuticals 52-Week Range
52-Week High:
38.08
52-Week Low:
21.99
Sell
38
Supernus Pharmaceuticals (SUPN)
is a Sell
Supernus Pharmaceuticals Share Price Forecast
-
What is the Supernus Pharmaceuticals stock price today?
The Supernus Pharmaceuticals stock price is 30.27 USD today. -
Will SUPN stock go up or go down?
Supernus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Supernus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals is overvalued.
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 30.27 while SUPN 8-day exponential moving average is 30.11, which is a Buy signal.
- The stock price of SUPN is 30.27 while Supernus Pharmaceuticals 20-day EMA is 30.53, which makes it a Sell.
- Supernus Pharmaceuticals 50-day exponential moving average is 30.75 while SUPN share price is 30.27, making it a Sell technically.
- SUPN stock price is 30.27 and Supernus Pharmaceuticals 200-day simple moving average is 30.22, creating a Buy signal.
Fundamental Analysis of Supernus Pharmaceuticals
Is Supernus Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.35 per share, and an increase next year of $0.31 per share.
Technical Analysis of Supernus Pharmaceuticals
Should I short Supernus Pharmaceuticals stock?
- SUPN Moving Average Covergence Divergence (MACD) indicator is -0.5, suggesting Supernus Pharmaceuticals is a Sell
- Supernus Pharmaceuticals Relative Strength Index (RSI) is 46.64, which suggest Supernus Pharmaceuticals is oversold
- The Bollinger Bands (25) for Supernus Pharmaceuticals is (29.39 - 32.67), which suggest Supernus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Supernus Pharmaceuticals is (27.5 - 32.08), which suggest Supernus Pharmaceuticals is a Buy
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.